Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials, the company said.
Assad Kazeminy, CEO and founder of Irvine Pharmaceutical Services, said: “We are very excited about this extension of our company. Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership.”